These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 17410658)
1. Trailblazers. Recent years have seen the addition of several new classes of diabetes drugs, each one heralded as "The Next Big Thing" in diabetes. Have they lived up to their promise? D'Arrigo T Diabetes Forecast; 2007; 60(3):32-4. PubMed ID: 17410658 [No Abstract] [Full Text] [Related]
2. [New classes of drugs in the pipeline. New in the treatment of diabetes mellitus]. Steri R; Schubert-Zsilavecz M Pharm Unserer Zeit; 2010 Mar; 39(2):142-6. PubMed ID: 20196042 [No Abstract] [Full Text] [Related]
3. Oral drugs in the treatment of diabetes mellitus. DeLawter DE Md State Med J; 1966 Oct; 15(10):28-34. PubMed ID: 5918083 [No Abstract] [Full Text] [Related]
4. [Oral drugs in the treatment of diabetes mellitus]. Lister J Xianggang Hu Li Za Zhi; 1981 May; (30):36-8. PubMed ID: 6457787 [No Abstract] [Full Text] [Related]
5. Treatment of diabetes with oral hypoglycemic drugs. Moss JM; DeLawter DE GP; 1966 Oct; 34(4):85-8. PubMed ID: 5912533 [No Abstract] [Full Text] [Related]
6. A 'touch' of diabetes? Saudek CD FDA Consum; 2002; 36(1):36. PubMed ID: 11881597 [No Abstract] [Full Text] [Related]
7. Drugs by mail or modem. Do they beat the corner drugstore? Roberts SS Diabetes Forecast; 2002 Jun; 55(6):35-7. PubMed ID: 14964165 [No Abstract] [Full Text] [Related]
8. [Modern oral sugar-reducing drugs: focus to glibenclamide]. Ushakova EA Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041 [No Abstract] [Full Text] [Related]
9. New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond. Inzucchi SE; McGuire DK Circulation; 2008 Jan; 117(4):574-84. PubMed ID: 18227398 [TBL] [Abstract][Full Text] [Related]
10. Metformin as an addition to conventional chemotherapy in breast cancer. Grenader T; Goldberg A; Shavit L J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518 [No Abstract] [Full Text] [Related]
12. Implications of new diabetes treatment trials: should current clinical practice be altered? Kravetz JD; Federman DG Postgrad Med; 2009 May; 121(3):67-72. PubMed ID: 19491542 [TBL] [Abstract][Full Text] [Related]
13. Dietary supplements in the management of diabetes: potential risks and benefits. Geil P; Shane-McWhorter L J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S59-65. PubMed ID: 18358258 [TBL] [Abstract][Full Text] [Related]
14. For the patient. Many nursing home patients do not receive diabetes medicine. Allsworth JE; Toppa R; Palin NC; Lapane KL Ethn Dis; 2005; 15(2):351. PubMed ID: 15825983 [No Abstract] [Full Text] [Related]
15. [Contributions to the ambulatory treatment of diabetes mellitus]. Kaufmann E; Krakobsky I; Alvarez Pérez AA Rev Clin Esp; 1966 Oct; 103(2):119-22. PubMed ID: 5997096 [No Abstract] [Full Text] [Related]
17. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy. Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559 [TBL] [Abstract][Full Text] [Related]
18. Drugs on the horizon. De Haen P N Y State J Med; 1972 Aug; 72(15):1969-73. PubMed ID: 4506215 [No Abstract] [Full Text] [Related]
19. [Drug interactions of selected drugs used by patients with diabetes mellitus]. Prokes M; Suchopár J Vnitr Lek; 2009 Apr; 55(4):395-402. PubMed ID: 19449757 [TBL] [Abstract][Full Text] [Related]
20. Oral hypoglycaemic drugs. O'Sullivan DJ Ir Med J; 1982 Jun; 75(6):178-82. PubMed ID: 7107183 [No Abstract] [Full Text] [Related] [Next] [New Search]